LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study

Obeso, 2017, Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy, Mov Disord, 32, 1264, 10.1002/mds.27115 Hely, 2008, The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years, Mov Disord, 23, 837, 10.1002/mds.21956 McKeith, 2005, Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium, Neurology, 65, 1863, 10.1212/01.wnl.0000187889.17253.b1 McKeith, 2017, Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium, Neurology, 89, 88, 10.1212/WNL.0000000000004058 Hogan, 2016, The prevalence and incidence of dementia with Lewy bodies: a systematic review, Can J Neurol Sci, 43, S83, 10.1017/cjn.2016.2 Walker, 2015, Lewy body dementias, Lancet, 386, 1683, 10.1016/S0140-6736(15)00462-6 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Singleton, 2013, The genetics of Parkinson's disease: progress and therapeutic implications, Mov Disord, 28, 14, 10.1002/mds.25249 Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 Paisan-Ruiz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 Sidransky, 2009, Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, N Engl J Med, 361, 1651, 10.1056/NEJMoa0901281 Nalls, 2013, A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies, JAMA Neurol, 70, 727, 10.1001/jamaneurol.2013.1925 Chang, 2017, A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci, Nat Genet, 49, 1511, 10.1038/ng.3955 Goedert, 2013, 100 years of Lewy pathology, Nat Rev Neurol, 9, 13, 10.1038/nrneurol.2012.242 Langston, 2015, Multisystem Lewy body disease and the other parkinsonian disorders, Nat Genet, 47, 1378, 10.1038/ng.3454 Friedman, 2018, Dementia with Lewy bodies and Parkinson disease dementia: it is the same disease!, Parkinsonism Relat Disord, 46, S6, 10.1016/j.parkreldis.2017.07.013 Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res, 38, e164, 10.1093/nar/gkq603 Jagadeesh, 2016, M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity, Nat Genet, 48, 1581, 10.1038/ng.3703 Vanhauwaert, 2017, The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals, EMBO J, 36, 1392, 10.15252/embj.201695773 Reinhardt, 2013, Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling, PLoS One, 8, e59252, 10.1371/journal.pone.0059252 Abecasis, 2002, Merlin: rapid analysis of dense genetic maps using sparse gene flow trees, Nat Genet, 30, 97, 10.1038/ng786 Pasanen, 2014, Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology, Neurobiol Aging, 35, 2180, 10.1016/j.neurobiolaging.2014.03.024 Kiely, 2015, Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation, Mol Neurodegener, 10, 41, 10.1186/s13024-015-0038-3 Montine, 2012, National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach, Acta Neuropathol, 123, 1, 10.1007/s00401-011-0910-3 Papadimitriou, 2016, Motor and nonmotor features of carriers of the p.A53T alpha-synuclein mutation: a longitudinal study, Mov Disord, 31, 1226, 10.1002/mds.26615 Goldwurm, 2011, Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease, Mov Disord, 26, 2144, 10.1002/mds.23807 Brodeur, 2009, Calnuc binds to LRP9 and affects its endosomal sorting, Traffic, 10, 1098, 10.1111/j.1600-0854.2009.00933.x Brodeur, 2012, LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease, Mol Neurodegener, 7, 31, 10.1186/1750-1326-7-31 Boucher, 2008, Intracellular trafficking of LRP9 is dependent on two acidic cluster/dileucine motifs, Histochem Cell Biol, 130, 315, 10.1007/s00418-008-0436-5 Doray, 2008, Identification of acidic dileucine signals in LRP9 that interact with both GGAs and AP-1/AP-2, Traffic, 9, 1551, 10.1111/j.1600-0854.2008.00786.x Zimprich, 2011, A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease, Am J Hum Genet, 89, 168, 10.1016/j.ajhg.2011.06.008 Vilarino-Guell, 2011, VPS35 mutations in Parkinson disease, Am J Hum Genet, 89, 162, 10.1016/j.ajhg.2011.06.001 Steinberg, 2013, A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport, Nat Cell Biol, 15, 461, 10.1038/ncb2721 Follett, 2014, The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer, Traffic, 15, 230, 10.1111/tra.12136 Tang, 2015, VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for alpha-synuclein degradation and prevention of pathogenesis of Parkinson's disease, J Neurosci, 35, 10613, 10.1523/JNEUROSCI.0042-15.2015 von Einem, 2017, The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (alpha-syn) oligomerization and secretion, Aging (Albany NY), 9, 1677, 10.18632/aging.101261 Chen, 2017, Randomized CRISPR-Cas transcriptional perturbation screening reveals protective genes against alpha-synuclein toxicity, Mol Cell, 68, 247, 10.1016/j.molcel.2017.09.014 Lee, 2014, Extracellular alpha–synuclein—a novel and crucial factor in Lewy body diseases, Nat Rev Neurol, 10, 92, 10.1038/nrneurol.2013.275